|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01099 SINOPHARM
Nominal 
21.960 +0.160 (+0.734%) Ranking Overview
Ranking based on 4 research report(s)
Average Ranking 2.25
|
Strong Buy (1)
0
|
Buy (2)
3
|
Hold (3)
1
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | 226.00 RMB (cts) | |
| Net Profit | 7,049.68 RMB (MIL) | DPS | 68.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | 7,228.50 | 231.60 | 69.80 | -- | 7,480.00 | 6,427.00 |
| 2026 | 7,672.00 | 245.50 | 73.50 | -- | 8,332.00 | 6,250.00 |
| 2027 | 8,203.50 | 263.00 | 79.00 | -- | 8,759.00 | 6,191.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | 7,242.00 | 232.00 | 70.00 | UBS | Buy | 24.20 | 27/10/2025 | |
| 2025 | 6,427.00 | 206.00 | 62.00 | FIRST SHANGHAI SEC | Buy | 21.30 | 26/09/2025 | |
| 2025 | 7,215.00 | 231.20 | 69.60 | DAIWA | OutPerform | 21.00 | 27/10/2025 | |
| 2025 | 7,480.00 | 240.00 | 72.00 | HSBC | Hold | 19.50 | 10/11/2025 | |
| 2026 | 7,403.00 | 237.00 | 71.00 | UBS | - | -- | 27/10/2025 | |
| 2026 | 6,250.00 | 200.00 | 60.00 | FIRST SHANGHAI SEC | - | -- | 26/09/2025 | |
| 2026 | 8,332.00 | 267.00 | 80.40 | DAIWA | - | -- | 27/10/2025 | |
| 2026 | 7,941.00 | 254.00 | 76.00 | HSBC | - | -- | 10/11/2025 | |
| 2027 | 7,868.00 | 252.00 | 76.00 | UBS | - | -- | 27/10/2025 | |
| 2027 | 6,191.00 | 198.00 | 59.00 | FIRST SHANGHAI SEC | - | -- | 26/09/2025 | |
| 2027 | 8,759.00 | 280.70 | 84.50 | DAIWA | - | -- | 27/10/2025 | |
| 2027 | 8,539.00 | 274.00 | 82.00 | HSBC | - | -- | 10/11/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 25/02/2026 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 3,465,686 |
| %Change | -6.431% |
| EPS / (LPS) | RMB 1.110 |
| NBV Per Share (¥) | RMB 25.710 |